HBLCX
Price
$14.63
Change
+$0.01 (+0.07%)
Updated
Jun 18 closing price
Net Assets
11.16B
NAARX
Price
$13.14
Change
+$0.02 (+0.15%)
Updated
Jun 18 closing price
Net Assets
1.42B
Interact to see
Advertisement

HBLCX vs NAARX

HBLCX vs NAARX Comparison Chart in %
View a ticker or compare two or three
VS
HBLCX vs. NAARX commentary
Jun 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLCX is a Hold and NAARX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLCX has more cash in the bank: 11.2B vs. NAARX (1.42B). NAARX pays higher dividends than HBLCX: NAARX (3.21) vs HBLCX (2.49). HBLCX was incepted earlier than NAARX: HBLCX (20 years) vs NAARX (11 years). HBLCX (1.65) is less costly to investors than NAARX (0.59). HBLCX is a more actively managed with annual turnover of: 90.00 vs. NAARX (6.00). NAARX has a lower initial minimum investment than HBLCX: NAARX (250) vs HBLCX (2000). NAARX annual gain was more profitable for investors over the last year : 10.90 vs. HBLCX (5.05). NAARX return over 5 years is better than : 22.73 vs. HBLCX (2.78).
HBLCXNAARXHBLCX / NAARX
Total Expense Ratio1.650.59280%
Annual Report Gross Expense Ratio1.650.59280%
Fund Existence20 years11 years-
Gain YTD3.3193.69590%
Front LoadN/A6%-
Min. Initial Investment2000250800%
Min. Initial Investment IRA2000N/A-
Net Assets11.2B1.42B791%
Annual Yield % from dividends2.493.2178%
Returns for 1 year5.0510.9046%
Returns for 3 years10.0722.1246%
Returns for 5 years2.7822.7312%
Returns for 10 years31.4953.2759%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIICX22.070.30
+1.38%
Fidelity Advisor Mid Cap II C
GSPFX20.850.16
+0.77%
Gotham Enhanced S&P 500 Index Instl
SMSAX10.710.03
+0.28%
SEI Multi Strategy Alternatives F (SIMT)
OANLX88.79-0.38
-0.43%
Oakmark Select Institutional
BIVSX14.47-0.38
-2.56%
Invenomic Super Institutional